Opportunity Information: Apply for CDC RFA GH13 1366
Apply for CDC RFA GH13 1366
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Supporting Laboratory Strengthening Activities in Resource Limited Countries under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Jul 29, 2015 and posted on Jun 25, 2015.
- Applicants must submit their applications by Sep 29, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $140,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $10,000,000.00 in funding.
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible ApplicantsEligible applicants that can apply for this funding opportunity are listed below Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non U.S.) entityA Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Supporting Laboratory Strengthening Activities in Resource Limited Countries under the President's Emergency Plan for AIDS Relief (PEPFAR) is a CDC cooperative agreement funding opportunity designed to improve and expand laboratory systems that support HIV/AIDS programs in resource-limited settings. Working under the leadership of the U.S. Global AIDS Coordinator, CDC intends to partner with host-country governments and other stakeholders to identify gaps in laboratory capacity and then implement targeted, country-specific assistance that aligns with each nation’s own strategic plans and partnership frameworks. In practice, this kind of opportunity typically supports efforts that make HIV-related testing and broader public health laboratory functions more reliable, timely, and sustainable, including improvements tied to quality systems, workforce development, and the infrastructure and processes needed to deliver accurate diagnostic and monitoring services.
The mechanism is a cooperative agreement, meaning recipients should expect substantial federal involvement in implementation, coordination, and oversight compared with a standard grant. The program falls under the Health activity category and is connected to CFDA 93.067 (Global AIDS), reflecting its placement within the broader U.S. government PEPFAR portfolio. The stated intent is not a one-size-fits-all package; instead, CDC’s approach emphasizes assessing local needs with country partners and tailoring activities to fit national strategies, which can include coordination with ministries of health, national reference laboratories, and implementing partners to strengthen systems across the testing network.
Funding levels indicate a large, multi-award initiative. CDC anticipated up to 50 awards with an estimated total funding amount of $140,000,000. Individual awards were expected to range from a floor of $100,000 up to a ceiling of $10,000,000, suggesting the opportunity could support both smaller targeted projects and large-scale national or multi-regional laboratory strengthening efforts depending on applicant scope and country needs. There was no cost-sharing or matching requirement, which generally lowers barriers to participation for organizations operating in resource-limited environments.
Eligibility was broad and inclusive across many organization types. Eligible applicants included U.S. and non-U.S. entities, nonprofits with or without 501(c)(3) status, for-profit organizations (other than small businesses), small/minority/women-owned businesses, universities and colleges, research institutions, hospitals, community-based and faith-based organizations, and a wide range of tribal and Native health entities (including tribal governments and tribal epidemiology centers). State and local governments (including U.S. territories and freely associated states listed in the announcement) could apply directly or through bona fide agents, with the requirement that a bona fide agent submit legal documentation demonstrating it has binding authorization to apply on behalf of the government entity. This breadth signals CDC’s interest in funding capable implementers across public, private, academic, and community sectors, as long as they can deliver technical and operational improvements to laboratory systems in alignment with PEPFAR goals.
Key administrative details place the opportunity in 2015. It was posted June 25, 2015, created July 29, 2015, with an original closing date of July 28, 2015, later extended to a current closing date of September 29, 2015, and archived October 29, 2015. The funding opportunity number was CDC RFA GH13-1366. For applicant support, CDC provided a point of contact through its Procurement and Grants Office (PGO), including a phone number (770-488-2700) and an email contact (pgotim@cdc.gov) for assistance accessing the full announcement and related materials.
Overall, this opportunity funded partners to strengthen laboratory capacity as a core enabler of effective HIV programs under PEPFAR, with CDC working closely with recipients and host-country stakeholders to design and carry out improvements that match national plans, reinforce health systems, and improve the quality and reach of laboratory services needed for HIV prevention, care, and treatment programs.
Frequently Asked Questions (FAQs)
What is the purpose of this funding opportunity?
This CDC cooperative agreement opportunity is intended to improve and expand laboratory systems that support HIV/AIDS programs in resource-limited countries under the President's Emergency Plan for AIDS Relief (PEPFAR). The focus is on strengthening laboratory capacity so HIV-related testing and broader public health laboratory functions are more reliable, timely, and sustainable.
What does "laboratory strengthening" mean in this announcement?
Based on the description provided, laboratory strengthening includes targeted, country-specific assistance to improve quality systems, workforce development, and the infrastructure and processes needed to deliver accurate diagnostic and monitoring services. Activities are designed to reinforce laboratory networks and the testing system that supports HIV prevention, care, and treatment programs.
Is this a grant or a cooperative agreement?
This opportunity uses a cooperative agreement mechanism. Recipients should expect substantial federal involvement in implementation, coordination, and oversight compared with a standard grant.
How is CDC expected to be involved during the project?
Because it is a cooperative agreement, CDC anticipates close involvement in implementation, coordination, and oversight. The opportunity also describes CDC working under the leadership of the U.S. Global AIDS Coordinator and partnering with host-country governments and stakeholders to identify gaps and implement tailored assistance.
Is this opportunity part of PEPFAR?
Yes. The opportunity is explicitly tied to the President's Emergency Plan for AIDS Relief (PEPFAR) and is described as part of the broader U.S. government PEPFAR portfolio.
What is the CFDA number and program area?
The program is connected to CFDA 93.067 (Global AIDS) and falls under the Health activity category.
Is the program approach standardized across countries?
No. The stated intent is not a one-size-fits-all package. CDC emphasizes assessing local needs with country partners and tailoring activities to fit national strategies and partnership frameworks.
Who does CDC expect recipients to coordinate with in-country?
The description indicates coordination may include ministries of health, national reference laboratories, and implementing partners, with the goal of strengthening systems across the testing network and aligning with each nation’s strategic plans and partnership frameworks.
How much funding was anticipated in total?
CDC anticipated an estimated total funding amount of $140,000,000 for this initiative.
How many awards were expected?
CDC anticipated up to 50 awards.
What was the expected size of individual awards?
Individual awards were expected to range from a minimum (floor) of $100,000 up to a maximum (ceiling) of $10,000,000. This suggests the opportunity could support both smaller targeted projects and larger-scale laboratory strengthening efforts depending on the proposed scope and country needs.
Was cost-sharing or matching required?
No. The opportunity states there was no cost-sharing or matching requirement.
Who was eligible to apply?
Eligibility was broad and included U.S. and non-U.S. entities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); small/minority/women-owned businesses; universities and colleges; research institutions; hospitals; community-based and faith-based organizations; and a wide range of tribal and Native health entities (including tribal governments and tribal epidemiology centers).
Could government entities apply?
Yes. State and local governments (including U.S. territories and freely associated states listed in the announcement) could apply directly or through bona fide agents, as described in the opportunity.
What is a "bona fide agent" requirement for government applicants?
If a government entity applies through a bona fide agent, the agent is required to submit legal documentation demonstrating it has binding authorization to apply on behalf of the government entity.
Are both U.S. and non-U.S. organizations eligible?
Yes. The eligibility list explicitly included both U.S. and non-U.S. entities.
What is the funding opportunity number?
The funding opportunity number is CDC RFA GH13-1366.
When was this opportunity posted and when did it close?
It was posted on June 25, 2015. The original closing date was July 28, 2015, and it was later extended to a current closing date of September 29, 2015.
When was the opportunity archived?
The opportunity was archived on October 29, 2015.
Who was the point of contact for applicant support?
CDC provided a point of contact through its Procurement and Grants Office (PGO). The phone number listed was 770-488-2700 and the email contact listed was pgotim@cdc.gov.
What kinds of outcomes is this opportunity trying to achieve?
The opportunity is intended to improve the quality and reach of laboratory services needed for HIV prevention, care, and treatment programs by strengthening laboratory capacity and systems as a core enabler of effective HIV programs under PEPFAR.
Does the opportunity emphasize sustainability?
Yes. The description highlights improving laboratory functions so they are more reliable, timely, and sustainable, including strengthening systems, workforce, and processes needed for accurate services.
Does the opportunity require alignment with national plans?
Yes. CDC’s approach emphasizes tailoring activities to align with each nation’s own strategic plans and partnership frameworks, and implementing targeted assistance based on identified local gaps.
Browse more opportunities from the same category: Health
Next opportunity: Feed the Future Liberia Agribusiness Development Activity (LADA)
Previous opportunity: Maghreb Sahel Corrections Reintegration Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 1366
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 1366) also looked into and applied for these:
| Funding Opportunity |
|---|
| Evaluation of STD Programs Deploying Disease Intervention Specialist (DIS) to Improve Human Immunodeficiency Virus (HIV) Outcomes Apply for CDC RFA PS15 1511 Funding Number: CDC RFA PS15 1511 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $750,000 |
| To Strengthen Collaboration Between CDC the National TB Controllers Association (NTCA) TB Nurse Coalition Supplement Project Apply for CDC RFA PS12 12050401SUPP15 Funding Number: CDC RFA PS12 12050401SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| Limited Competition Small Grant Program for NHLBI K01/K08/K23 Recipients (R03) Apply for RFA HL 16 020 Funding Number: RFA HL 16 020 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Service Delivery and Support for Orphans and Vulnerable Children (SDS OVC MZ) Apply for RFA 656 15 000006 Funding Number: RFA 656 15 000006 Agency: Mozambique USAID Maputo Category: Health Funding Amount: $72,000,000 |
| Service Area Competition Apply for HRSA 16 004 Funding Number: HRSA 16 004 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50) Apply for RFA NS 16 002 Funding Number: RFA NS 16 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Networks to Develop Priority Areas of Behavioral and Social Research (R24) Apply for RFA AG 16 008 Funding Number: RFA AG 16 008 Agency: National Institutes of Health Category: Health Funding Amount: $175,000 |
| Tuberculosis Elimination and Laboratory Cooperative Agreement Apply for CDC RFA PS15 150102CONT16 Funding Number: CDC RFA PS15 150102CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands Apply for CDC RFA PS13 130104CONT16 Funding Number: CDC RFA PS13 130104CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| The Biomedical Advanced Research and Development Authority Special Projects Apply for EP IDS 15 002 Funding Number: EP IDS 15 002 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $200,000 |
| International Research Scientist Development Award (IRSDA) (K01) Apply for PAR 15 291 Funding Number: PAR 15 291 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research to Address Health Disparities (Admin Supp) Apply for PA 15 293 Funding Number: PA 15 293 Agency: National Institutes of Health Category: Health Funding Amount: $45,000 |
| Tuberculosis Regional Training and Medical Consultation Centers Apply for CDC RFA PS13 130404CONT16 Funding Number: CDC RFA PS13 130404CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Project (Collaborative U01) Apply for RFA AA 16 001 Funding Number: RFA AA 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Resource Core (U24) Apply for RFA AA 16 003 Funding Number: RFA AA 16 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Limited Competition Consortia for HIV/AIDS and Alcohol Related Research Trials (CHAART) Administrative Resource Core (U24) Apply for RFA AA 16 002 Funding Number: RFA AA 16 002 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Smallpox Research Oversight ActivitiesWHO Advisory Committee on Variola Virus Research Apply for EP IDS 15 003 Funding Number: EP IDS 15 003 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $315,000 |
| Claude D. Pepper Older Americans Independence Centers (P30) Apply for RFA AG 16 011 Funding Number: RFA AG 16 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01) Apply for PA 15 295 Funding Number: PA 15 295 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Patient Centered Outcomes Research Clinical Decision Support Learning Network (U18) Apply for RFA HS 15 003 Funding Number: RFA HS 15 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 1366", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.